Alignment Healthcare, Inc. reported robust financial results for its second quarter ended June 30, 2025, including its first-ever GAAP net income. Total revenue for Q2 2025 reached $1.02 billion, marking a 49% increase year-over-year from Q2 2024.
The company achieved an adjusted gross profit of $130.5 million, up 76.3% year-over-year, and adjusted EBITDA of $28.5 million, compared to a loss of $1.5 million in Q2 2024. The Medical Benefits Ratio improved to 87.2% from 90.1% in the prior year period, reflecting enhanced cost management.
Building on this strong performance, Alignment Healthcare significantly raised its full-year 2025 financial guidance across all key metrics. The company now expects revenue between $3.88 billion and $3.93 billion, adjusted gross profit between $460 million and $475 million, and adjusted EBITDA between $70 million and $80 million.
This updated outlook represents a substantial increase from previous guidance, signaling strong confidence in continued operational excellence and profitability. The achievement of GAAP net income is a significant milestone for the company.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.